SG11202006144XA - Composition for protecting cornea - Google Patents

Composition for protecting cornea

Info

Publication number
SG11202006144XA
SG11202006144XA SG11202006144XA SG11202006144XA SG11202006144XA SG 11202006144X A SG11202006144X A SG 11202006144XA SG 11202006144X A SG11202006144X A SG 11202006144XA SG 11202006144X A SG11202006144X A SG 11202006144XA SG 11202006144X A SG11202006144X A SG 11202006144XA
Authority
SG
Singapore
Prior art keywords
composition
cornea
protecting
protecting cornea
Prior art date
Application number
SG11202006144XA
Inventor
Hanako Ikeda
Akira Kakizuka
Shigeru Kinoshita
Takahiro Nakamura
Maho Nagata
Noriko Koizumi
Naoki Okumura
Original Assignee
Univ Kyoto
Kyoto Prefectural Public Univ Corp
The Doshisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kyoto, Kyoto Prefectural Public Univ Corp, The Doshisha filed Critical Univ Kyoto
Publication of SG11202006144XA publication Critical patent/SG11202006144XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202006144XA 2017-12-27 2018-12-26 Composition for protecting cornea SG11202006144XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017251839 2017-12-27
PCT/JP2018/047749 WO2019131720A1 (en) 2017-12-27 2018-12-26 Composition for corneal protection

Publications (1)

Publication Number Publication Date
SG11202006144XA true SG11202006144XA (en) 2020-07-29

Family

ID=67063715

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202006144XA SG11202006144XA (en) 2017-12-27 2018-12-26 Composition for protecting cornea

Country Status (11)

Country Link
US (1) US20210059995A1 (en)
EP (1) EP3733177B1 (en)
JP (1) JP7165358B2 (en)
KR (1) KR102679880B1 (en)
CN (1) CN111757733A (en)
DK (1) DK3733177T3 (en)
ES (1) ES2925638T3 (en)
PL (1) PL3733177T3 (en)
PT (1) PT3733177T (en)
SG (1) SG11202006144XA (en)
WO (1) WO2019131720A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900011985A1 (en) * 2019-07-17 2021-01-17 Vision Eng Italy Srl Liquid formulation, in particular to treat a corneal tissue
US20220401461A1 (en) 2019-10-24 2022-12-22 Kyoto University Pharmaceutical Composition for Protecting Cartilage
JP2022170472A (en) 2021-04-28 2022-11-10 国立大学法人京都大学 Composition for ameliorating abnormality in skin tissue
JPWO2023120704A1 (en) 2021-12-24 2023-06-29

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2594556T3 (en) 2010-07-30 2016-12-21 Daito Chemix Corporation Naphthalene Derivative
ES2574832T3 (en) * 2010-09-30 2016-06-22 Kyoto University Agent for the treatment of eye diseases
DK2959903T3 (en) 2013-02-20 2019-01-21 Univ Kyoto Medicine for the treatment of eye disease
JP6628252B2 (en) 2014-02-28 2020-01-08 国立大学法人京都大学 Pharmaceutical composition for treatment of ischemic eye disease
JPWO2017222042A1 (en) * 2016-06-24 2019-04-11 国立大学法人京都大学 Ophthalmic pharmaceutical composition

Also Published As

Publication number Publication date
EP3733177A4 (en) 2021-10-27
PT3733177T (en) 2022-09-02
PL3733177T3 (en) 2022-11-14
US20210059995A1 (en) 2021-03-04
KR20200123095A (en) 2020-10-28
JPWO2019131720A1 (en) 2020-12-10
EP3733177B1 (en) 2022-07-06
KR102679880B1 (en) 2024-07-02
DK3733177T3 (en) 2022-10-10
WO2019131720A1 (en) 2019-07-04
CN111757733A (en) 2020-10-09
EP3733177A1 (en) 2020-11-04
JP7165358B2 (en) 2022-11-04
ES2925638T3 (en) 2022-10-19

Similar Documents

Publication Publication Date Title
GB201913962D0 (en) Ophthalmic drug compositions
PT3426226T (en) Ophthalmological composition
PL3373973T3 (en) Ocular compositions
GB2568579B (en) Ophthalmic drug compositions
PL3452075T3 (en) Ophthalmic pharmaceutical composition
GB201703455D0 (en) Composition
SG11202006144XA (en) Composition for protecting cornea
GB201707120D0 (en) Composition
SG11201707117SA (en) Ophthalmic composition
GB201619525D0 (en) Ophthalmic composition
GB201707462D0 (en) Ocular compositions
GB201707238D0 (en) Composition
GB201700504D0 (en) Composition
GB201713636D0 (en) Composition
GB201712151D0 (en) Composition
RS60926B1 (en) Ophthalmic composition for the corneal protection
HK1255867A1 (en) Composition for optic nerve protection
EP3675653C0 (en) Antimycotoxin composition
AU201714108S (en) Finger Protector for Mandoline
GB201702833D0 (en) Composition
EP3570815C0 (en) Composition for ophthalmic use
LT3519050T (en) Compositions for treating ophthalmic conditions
PL3446682T3 (en) Ophthalmic composition
GB201711446D0 (en) Composition
GB201707920D0 (en) Composition